Previous close | 202.80 |
Open | 202.11 |
Bid | 198.59 x 1300 |
Ask | 205.52 x 800 |
Day's range | 200.41 - 202.21 |
52-week range | 185.22 - 254.00 |
Volume | |
Avg. volume | 491,703 |
Market cap | 20.039B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 35.61 |
EPS (TTM) | 5.66 |
Earnings date | 08 May 2024 |
Forward dividend & yield | 2.08 (1.03%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | 239.86 |
DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing fin
STERIS (STE) is expected to have witnessed the normalization of the Healthcare backlog, as the company is currently able to ship at a faster pace than the receipt of new orders.
STERIS (NYSE:STE) has had a rough month with its share price down 13%. We, however decided to study the company's...